Specialty Pharmacy

Genetic variation can cause severe acute pancreatitis from chemotherapy in patients with acute lymphoblastic leukemia (ALL).

Vegetative area levels linked to significant decreases in diabetes, chronic illnesses, high cholesterol, and hypertension.

Obinutuzumab (Gazyva) is an engineered monoclonal antibody designed to attach to the CD20 protein.

Remicade treats rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, plaque psoriasis, and ulcerative colitis.

Lixisenatide is an investigational fixed-ratio combination of basal insulin glargine 100 Units/mL and GLP-1 receptor agonist for adults with type 2 diabetes.

Top news of the week on Specialty Pharmacy Times.

Acute exenatide administration reduces glucose production and insulin resistance in liver tissue.

Top news of the day from across the healthcare landscape.

Organ recipients with a history of cancer were 1.5 times more likely to die early from any cause compared with organ recipients without history of cancer.

Annual specialty drug spending found to be 17% higher per member in the individual market compared with the employer market.

Neutron crystallography improves insight about the enzyme HIV-1 protease.

Research could lead to new treatments for amyotrophic lateral sclerosis and frontotemporal dementia.

Autumn Bagwell, PharmD, BCPS, clinical pharmacist at Vanderbilt Specialty Pharmacy, discusses the elements of an effective interdisciplinary collaborative patient management program.

Use of statins may lower the risk of prostate cancer associated with high fat intake.

Granulin implicated in the spread of cancer from the pancreas to the liver.

Adalimumab took an average of four months to clear from infants’ bodies, while infliximab took an average of 7.33 months.

Top news of the day from across the health care landscape.

Treatments for hereditary angioedema, hematologic conditions, and cancer among most expensive medications.

Medicare patients paid more out-of-pocket for the most expensive drugs compared with commercially insured patients.

Novel HCV regimen shows high SVR12 rates at 8 and 12 weeks of treatment.

Keytruda is a humanized monoclonal antibody that increases the ability of the immune system to detect and fight tumor cells.

Survey indicates a disconnect among caregivers and the RA patients they treat.

Stereotactic body radiation therapy shows 98% cure rate in first-time prostate cancer patients.

The biological mechanisms underlying the association between a successful plasma analysis and the age of non-small cell lung cancer patients are not fully understood.

Top news of the day from across the health care landscape.

Andrographis paniculata plant reduces fatigue in patients with relapsing-remitting multiple sclerosis.

Bacteria frequently found deep inside the lungs of chronic obstructive pulmonary disease patients.

Lack of enrollment in clinical trials hinder advancement of cancer therapy.